U.S. FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The agency said it would now allow compounding pharmacies and facilities to provide the drugs while it reviews if there
Read MoreThe agency said it would now allow compounding pharmacies and facilities to provide the drugs while it reviews if there
Read MoreHealth-care costs are going up, and yet workers may still not get the coverage they want — particularly when it
Read MoreDanish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market dominated
Read MoreStarboard's Jeff Smith called on the company to assemble a special committee to investigate the matter, describing it as "flagrantly
Read MoreStarboard's stake comes amid a time of struggle at the drugmaker, which has begun to cut costs aggressively as demand
Read MoreA breakup would be a stunning reversal for CVS, which has spent tens of billions of dollars on acquisitions to
Read MoreBooming demand for blockbuster weight-loss drugs like Ozempic and Mounjaro is being tested by a ports strike hitting import hubs
Read MoreCVS Health's board has engaged advisors to conduct a strategic review of its business, according to people familiar with the
Read MoreGlenview Capital is expected to meet with CVS management on Monday to discuss its plans for value creation at the
Read More